Christian Haass

Christian Haass

Christian Haass graduated in molecular biology at the University of Heidelberg. He was a postdoc and assistant professor of neurology at the Harvard Medical School in the Center for Neurological Diseases (1990-1995). In 1995 he was appointed as an associate professor of molecular biology at the Central Institute of Mental Health in Mannheim. Since 1999 he is the head of the division of Biochemistry of the Biomedical Research Center (BMC) of the Ludwig-Maximilians University and speaker of the German Center for Neurodegenerative Diseases (DZNE) in Munich. Christian Haass coordinates the Munich Cluster for Systems Neurology (SyNergy) within the German Excellence Initiative funded by the Deutsche Forschungsgemeinschaft (DFG). He is a member of the European Molecular Biology Organization (EMBO), the Leopoldina, the Bavarian Academy of Sciences and Humanities, and a member of the board of the Nomis Foundation and the Hans and Ilse Breuer Foundation.

Honors and Awards

  • 1997 Award of the Heidelberg Academy of Sciences
  • 2000 International Alois Alzheimer Award
  • 2002 Family Hansen Award
  • Ernst Jung Award for Medicine
  • Gottfried Wilhelm Leibniz-Award of the Deutsche Forschungsgemeinschaft (DFG)
  • Potamkin Award of the American Academy of Neurology 
  • 2006 MetLife Foundation Promising Award for Medical Research 
  • Sheik Hamdan Award for Medical Sciences 
  • 2010 Honorary Degree of the University of Zurich
  • 2012 ERC advanced grant
  • 2014 Order of Merit on Ribbon from the Federal Republic of Germany
  • 2015 MetLife Award for Medical Research
  • 2016 Rolf Becker Award
  • 2018 Reinhard Koselleck Project of the Deutsche Forschungsgemeinschaft (DFG)

Research Interest

Christian Haass’ research is concerned with the molecular and cellular mechanisms of neurodegeneration with a strong focus on Alzheimer’s disease and Frontotemporal Dementia. Using interdisciplinary approaches he investigates the pathomechanisms, which lead to the deposition of insoluble disease characterizing neurotoxic protein aggregates such as amyloid plaques in the brains of Alzheimer’s patients. Very recently he developed a strong interest in neuroinflammation and in translation of his findings from fundamental research to patients with dementia.